Polymer Composite May Eliminate Bone Formation in Soft Tissue

With support from a 3-year, $2.9 million grant from the U.S. Department of Defense, researchers at Carnegie Mellon University, the U.S. Military Academy and the Naval Medical Center are developing nanostructural polymer-based treatments that may eliminate the pathological formation of bone in soft tissue that commonly follows orthopaedic surgeries and limb amputations.

Data indicates that heterotopic ossification occurs in >60% of military personnel who incur bone injury resulting in amputation. Further, >90% of hip replacement procedures in the civilian U.S. population show signs of ossification.

The research team is focusing upon a nanostructural polymer composite to deliver a ribonucleic acid directly to cells at the trauma site. CMU researchers report there is a patent pending on the therapy and a clinical trial schedule will be developed once the preventative platform is fully lab-tested.

REFERENCES

CMU Research Team Develops Tools to Ease the Pain of Combat Injuries, August 31, 2012, www.cmu.edu
Bone Tissue Engineering Center Gets Grant to Help Soldiers, June 2012, www.cmu.edu

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE